Skip to main content
SpringerLink
Log in

Prognostic value of tumoral heterogeneity and volumetric parameters as measured by F18-FDG PET/CT in sinonasal cancer

  • Rhinology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

The objective of this study was to investigate the value of parameters assessed with F18-FDG PET/CT in predicting recurrence-free survival (RFS) and disease-specific survival (DSS) in patients with cancer of nasal cavity and paranasal sinus. Thirty-eight patients with cancer of nasal cavity (n = 14) and paranasal sinus (n = 24) who underwent PET/CT prior to curative treatment were enrolled. A volume of interest was placed on PET/CT images covering the entire tumor volume, and the maximum SUV (SUVmax), the mean SUV (SUVmean), and volumetric parameters of metabolic tumor volume (MTV) and total lesion glycolysis (TLG) were measured using thresholds of 40 % of SUVmax. The heterogeneity factor (HF) defined as the derivative of volume-threshold function from 40 to 80 % of SUV thresholds. RFS and DSS were defined as the time from the diagnosis to recurrence and death. Median values of SUVmax, SUVmean, MTV, TLG, and HF were 14.81, 9.16, 25.84, 150.74, and −0.496. SUVmax was higher in patients with advanced stage and nodal metastasis. High MTV and low HF group showed shorter RFS. Cox proportional hazards regression analysis revealed low HF was the only significant predictive factor on RFS. Furthermore, high TLG was associated with shorter DSS. High TLG was potent predictor of DSS by Cox proportional hazards regression analysis. In conclusion, the tumoral heterogeneity and volumetric parameters as measured by F18-FDG PET/CT could be significant prognostic surrogate markers in patients with sinonasal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Haerle SK, Gullane PJ, Witterick IJ, Zweifel C, Gentili F (2013) Sinonasal carcinomas: epidemiology, pathology, and management. Neurosurg Clin N Am 24:39–49

    Article  PubMed  Google Scholar 

  2. Turner JH, Reh DD (2012) Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data. Head Neck 34:877–885

    Article  PubMed  Google Scholar 

  3. Khademi B, Moradi A, Hoseini S, Mohammadianpanah M (2009) Malignant neoplasms of the sinonasal tract: report of 71 patients and literature review and analysis. Oral Maxillofac Surg 13:191–199

    Article  PubMed  Google Scholar 

  4. Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T (2001) Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer 92:3012–3029

    Article  CAS  PubMed  Google Scholar 

  5. Cantu G, Bimbi G, Miceli R, Mariani L, Colombo S, Riccio S et al (2008) Lymph node metastases in malignant tumors of the paranasal sinuses: prognostic value and treatment. Arch Otolaryngol Head Neck Surg 134:170–177

    Article  PubMed  Google Scholar 

  6. Moon SH, Choi JY, Lee HJ, Son YI, Baek CH, Ahn YC et al (2015) Prognostic value of volume-based positron emission tomography/computed tomography in patients with nasopharyngeal carcinoma treated with concurrent chemoradiotherapy. Clin Exp Otorhinolaryngol 8:142–148

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Dibble EH, Alvarez AC, Truong MT, Mercier G, Cook EF, Subramaniam RM et al (2012) 18F-FDG metabolic tumor volume and total glycolytic activity of oral cavity and oropharyngeal squamous cell cancer: adding value to clinical staging. J Nucl Med 53:709–715

    Article  CAS  PubMed  Google Scholar 

  8. Suzuki H, Kato K, Fujimoto Y, Itoh Y, Hiramatsu M, Naganawa S et al (2014) Prognostic value of (18)F-fluorodeoxyglucose uptake before treatment for pharyngeal cancer. Ann Nucl Med 28:356–362

    Article  CAS  PubMed  Google Scholar 

  9. Abgral R, Keromnes N, Robin P, Le Roux PY, Bourhis D, Palard X et al (2014) Prognostic value of volumetric parameters measured by 18F-FDG PET/CT in patients with head and neck squamous cell carcinoma. Eur J Nucl Med Mol Imaging 41:659–667

    Article  CAS  PubMed  Google Scholar 

  10. Paidpally V, Chirindel A, Chung CH, Richmon J, Koch W, Quon H et al (2014) FDG volumetric parameters and survival outcomes after definitive chemoradiotherapy in patients with recurrent head and neck squamous cell carcinoma. AJR Am J Roentgenol 203:W139–W145

    Article  PubMed  PubMed Central  Google Scholar 

  11. Yang Z, Shi Q, Zhang Y, Pan H, Yao Z, Hu S et al (2015) Pretreatment (18)F-FDG uptake heterogeneity can predict survival in patients with locally advanced nasopharyngeal carcinoma—a retrospective study. Radiat Oncol 10(1):4

    Article  PubMed  PubMed Central  Google Scholar 

  12. Miller TR, Grigsby PW (2002) Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy. Int J Radiat Oncol Biol Phys 53:353–359

    Article  PubMed  Google Scholar 

  13. Soret M, Bacharach SL, Buvat I (2007) Partial-volume effect in PET tumor imaging. J Nucl Med 48:932–945

    Article  PubMed  Google Scholar 

  14. Son SH, Kim DH, Hong CM, Kim CY, Jeong SY, Lee SW et al (2014) Prognostic implication of intratumoral metabolic heterogeneity in invasive ductal carcinoma of the breast. BMC Cancer 14:585

    Article  PubMed  PubMed Central  Google Scholar 

  15. Huang B, Chan T, Kwong DL, Chan WK, Khong PL (2012) Nasopharyngeal carcinoma: investigation of intratumoral heterogeneity with FDG PET/CT. AJR Am J Roentgenol 199:169–174

    Article  PubMed  Google Scholar 

  16. Kidd EA, Grigsby PW (2008) Intratumoral metabolic heterogeneity of cervical cancer. Clin Cancer Res 14:5236–5241

    Article  CAS  PubMed  Google Scholar 

  17. Im HJ, Pak K, Cheon GJ, Kang KW, Kim SJ, Kim IJ et al (2015) Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer: a meta-analysis. Eur J Nucl Med Mol Imaging 42:241–251

    Article  CAS  PubMed  Google Scholar 

  18. Soydal C, Yuksel C, Kucuk NO, Okten I, Ozkan E, Doganay Erdogan B (2014) Prognostic value of metabolic tumor volume measured by 18F-FDG PET/CT in esophageal cancer patients. Mol Imaging Radionucl Ther 23:12–15

    Article  PubMed  PubMed Central  Google Scholar 

  19. Lee HS, Kim HO, Hong YS, Kim TW, Kim JC, Yu CS et al (2014) Prognostic value of metabolic parameters in patients with synchronous colorectal cancer liver metastasis following curative-intent colorectal and hepatic surgery. J Nucl Med 55:582–589

    Article  PubMed  Google Scholar 

  20. Hong SP, Lee SE, Choi YL, Seo SW, Sung KS, Koo HH et al (2014) Prognostic value of 18F-FDG PET/CT in patients with soft tissue sarcoma: comparisons between metabolic parameters. Skelet Radiol 43:641–648

    Article  Google Scholar 

  21. Gallicchio R, Mansueto G, Simeon V, Nardelli A, Guariglia R, Capacchione D et al (2014) F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma. Eur J Haematol 92:382–389

    Article  CAS  PubMed  Google Scholar 

  22. Ramakrishnan VR, Lee JY, O’Malley BW Jr, Palmer JN, Chiu AG (2013) 18-FDG-PET in the initial staging of sinonasal malignancy. Laryngoscope 123:2962–2966

    Article  PubMed  Google Scholar 

  23. La TH, Filion EJ, Turnbull BB, Chu JN, Lee P, Nguyen K et al (2009) Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer. Int J Radiat Oncol Biol Phys 74:1335–1341

    Article  PubMed  PubMed Central  Google Scholar 

  24. Pak K, Cheon GJ, Nam HY, Kim SJ, Kang KW, Chung JK et al (2014) Prognostic value of metabolic tumor volume and total lesion glycolysis in head and neck cancer: a systematic review and meta-analysis. J Nucl Med 55:884–890

    Article  CAS  PubMed  Google Scholar 

  25. van Velden FH, Cheebsumon P, Yaqub M, Smit EF, Hoekstra OS, Lammertsma AA et al (2011) Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoral FDG uptake in non-small cell lung cancer PET studies. Eur J Nucl Med Mol Imaging 38:1636–1647

    Article  PubMed  PubMed Central  Google Scholar 

  26. Pugachev A, Ruan S, Carlin S, Larson SM, Campa J, Ling CC et al (2005) Dependence of FDG uptake on tumor microenvironment. Int J Radiat Oncol Biol Phys 62:545–553

    Article  CAS  PubMed  Google Scholar 

  27. Zhao S, Kuge Y, Mochizuki T, Takahashi T, Nakada K, Sato M et al (2005) Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor. J Nucl Med 46:675–682

    CAS  PubMed  Google Scholar 

  28. Kang SR, Song HC, Byun BH, Oh JR, Kim HS, Hong SP et al (2014) Intratumoral metabolic heterogeneity for prediction of disease progression after concurrent chemoradiotherapy in patients with inoperable stage III non-small-cell lung cancer. Nucl Med Mol Imaging 48:16–25

    Article  CAS  PubMed  Google Scholar 

  29. Eary JF, O’Sullivan F, O’Sullivan J, Conrad EU (2008) Spatial heterogeneity in sarcoma 18F-FDG uptake as a predictor of patient outcome. J Nucl Med 49:1973–1979

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University School of Medicine, Pusan National University Hospital, Busan, Republic of Korea

    Bum Soo Kim, Kyoungjune Pak & In Joo Kim

  2. Department of Otorhinolaryngology and Biomedical Research Institute, Pusan National University School of Medicine, Pusan National University Hospital, 179 Gudeok-Ro, Seo-gu, Busan, 602-739, Republic of Korea

    Keun-Ik Yi & Kyu-Sup Cho

  3. Department of Otorhinolaryngology and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea

    Hwan-Jung Roh

Authors
  1. Bum Soo Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kyoungjune Pak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Keun-Ik Yi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. In Joo Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hwan-Jung Roh
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kyu-Sup Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kyu-Sup Cho.

Ethics declarations

The authors have no funding, financial relationships, or conflicts of interest to disclose.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, B.S., Pak, K., Yi, KI. et al. Prognostic value of tumoral heterogeneity and volumetric parameters as measured by F18-FDG PET/CT in sinonasal cancer. Eur Arch Otorhinolaryngol 274, 1437–1443 (2017). https://doi.org/10.1007/s00405-016-4346-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-016-4346-1

Keywords

Search

Navigation